Molecular NeurodegenerationGenetic & Genomic MedicinePeer-reviewed journal article
Identification of a specific APOE transcript and functional elements associated with Alzheimer's disease
Qiang CheniD, Luis Aguirre, Guoming LiangiD, Huanhuan ZhaoiD, Tao Dong, Felix Borrego, Itziar de RojasiD, Qichan Hu, Christopher Reyes, Ling‐Yan SuiD, Bao ZhangiD, James Donald LechleiteriD, Harald H.H. GöringiD, Philip L. De JageriD, Joel E. KleinmaniD, Thomas M. HydeiD, Pan P. LiiD, Agustı́n RuiziD, Daniel R. WeinbergeriD, Sudha S. SeshadriiD, Liang MaiD
Abstract
INTRODUCTIONThe APOE gene is the strongest genetic risk factor for late-onset Alzheimers Disease (LOAD). However, the gene regulatory mechanisms at this locus have not been fully characterized. METHODSTo identify novel AD-linked functional elements within the APOE locus, we integrated SNP variants with RNA-seq, DNA methylation, and ChIP-seq data from human postmortem brains. RESULTSWe identified an AD-linked APOE transcript (jxn1.2.2) observed in the dorsolateral prefrontal cortex (DLPFC). The APOE jxn1.2.2 transcript is associated with brain neuropathological features in DLPFC. We prioritized an independent functional SNP, rs157580, significantly associated with jxn1.2.2 transcript abundance and DNA methylation levels. rs157580 is located within active chromatin regions and predicted to affect brain-related transcriptional factors binding affinity. rs157580 shared the effects on the jxn1.2.2 transcript between European and African ethnic groups. DISCUSSIONThe novel APOE functional elements provide potential therapeutic targets with mechanistic insight into the diseases etiology.
- organism: human
- assay: DNA methylation
- assay: ChIP-seq
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 5
- FWCI
- 1.41
- Field percentile
- top 19%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- APOE E4 Alzheimer's Risk Converges on an Oligodendrocyte Subtype in the Human Entorhinal Cortex
Louise A. Huuki-Myers, Heena R. Divecha, … Leonardo Collado‐Torres·bioRxiv·Nov 20, 2025
- African origin haplotype protective for Alzheimer's disease in APOEϵ4 carriers: exploring potential mechanisms
Luciana Bertholim Nasciben, Karen Nuytemans, … Jeffery M. Vance·bioRxiv·Oct 24, 2024
- Allele-specific alternative polyadenylation links noncoding genetic variation to Alzheimer's disease risk
Ryan M. Barney, Giovanni Quinones-Valdez, … Xinshu Grace Xiao·bioRxiv·Feb 15, 2026
- Haplotype-Resolved DNA Methylation at the APOE Locus identifies Allele-Specific Epigenetic Signatures Relevant to Alzheimer's Disease Risk
Rylee M. Genner, Melissa Meredith, … Kimberley J. Billingsley·npj DementiaPeer-reviewed·Jun 19, 2026
- In vivo validation of late-onset Alzheimer's disease genetic risk factors
Michael Sasner, Christoph Preuß, … Gregory W. Carter·Alzheimer s & DementiaPeer-reviewed·Apr 30, 2024
- Exome-wide age-of-onset analysis reveals exonic variants in ERN1, TACR3 and SPPL2C associated with Alzheimer's disease
Liang He, Yury Loika, … Alzheimer’s Disease Neuroimaging Initiative·Translational PsychiatryPeer-reviewed·Feb 26, 2021